Research Moratoria and Off-Label Use of Ketamine

&
American Journal of Bioethics 16 (4):60-61 (2016)
  Copy   BIBTEX

Abstract

We wish to point out an additional consequence of the Catch-22 described by Andreae and colleagues (Andreae et al. 2016). The decades-long research gridlock of controlled drugs has unintentionally...

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2016.1145285

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,168

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.Melvyn W. Zhang, Keith M. Harris & Roger C. Ho - 2016 - BMC Medical Ethics 17 (1):1-8.
Ketamine Enhanced Psychotherapy: Preliminary Clinical Observations on its Effectiveness in Treating Death Anxiety.Eli Kolp, M. Young, Harris Friedman, Evgeny Krupitsky & Karl Jansen - 2007 - International Journal of Transpersonal Studies 26 (1):1-17.
Ketamine as a primary predictor of out-of-body experiences associated with multiple substance use.Leanne K. Wilkins, Todd A. Girard & J. Allan Cheyne - 2011 - Consciousness and Cognition 20 (3):943-950.
The ketamine model for schizophrenia.Murray Alpert & Burt Angrist - 2003 - Behavioral and Brain Sciences 26 (1):82-83.
Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics.Claudia Wiesemann - 2009 - European Journal of Pediatrics 168:1473-1478.
Exploring space consciousness other dissociative experiences: a Japanese perspective.Ornella Corazza - 2010 - Journal of Consciousness Studies 17 (7-8):7-8.
Speaking Off Label.Stephen R. Latham - 2010 - Hastings Center Report 40 (6):9-10.
Consent to open label extension studies: some ethical issues.P. Wainwright - 2002 - Journal of Medical Ethics 28 (6):373-376.
Beyond Bench and Bedside: Disentangling the Concept of Translational Research.Anna Laura van der Laan & Marianne Boenink - 2015 - Health Care Analysis 23 (1):32-49.
Beyond Bench and Bedside: Disentangling the Concept of Translational Research. [REVIEW]Anna Laura Laan & Marianne Boenink - 2012 - Health Care Analysis (1):1-18.
Rooting Out Institutional Corruption to Manage Inappropriate Off‐Label Drug Use.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):654-664.
Off-Label Drug Use as a Consent and Health Regulation Issue in New Zealand.Rebecca Julia Cook - 2015 - Journal of Bioethical Inquiry 12 (2):251-258.
Off-Label Prescribing: A Call for Heightened Professional and Government Oversight.Rebecca Dresser & Joel Frader - 2009 - Journal of Law, Medicine and Ethics 37 (3):476-486.
A systems model of altered consciousness: Integrating natural and drug-induced psychoses.Franz X. Vollenweider & Mark A. Geyer - 2001 - Brain Research Bulletin. Special Issue 56 (5):495-507.
Toward an Explanation of the Genesis of Ketamine-Induced Perceptual Distortions and Hallucinatory States.Alfredo Pereira Jr - 2003 - Brain and Mind 4 (3):307-326.

Analytics

Added to PP
2016-03-17

Downloads
16 (#909,581)

6 months
3 (#981,849)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Dominic Sisti
University of Pennsylvania

Citations of this work

Ethics and ego dissolution: the case of psilocybin.William R. Smith & Dominic Sisti - 2021 - Journal of Medical Ethics 47 (12):807-814.

Add more citations

References found in this work

Medical Marijuana 2010: It's Time to Fix the Regulatory Vacuum.Peter J. Cohen - 2010 - Journal of Law, Medicine and Ethics 38 (3):654-666.
Medical Marijuana 2010: It's Time to Fix the Regulatory Vacuum.Peter J. Cohen - 2010 - Journal of Law, Medicine and Ethics 38 (3):654-666.

Add more references